title: Germ cell testis cancer: 15-year review.
abstract: Testis cancer affects 2-3 men per every 100,000 in the United States, making it the most common solid tumor of men in the 20-35-year-old age range. Since the average age of active duty military personnel is included in the age range of those at greatest risk for germ cell testis cancer, it is of pertinent clinical importance to physicians who treat these young patients. The National Naval Medical Center has been using cisplatin-based protocols since the time of their introduction. This study reviews the success of treating these patients and examines the treatment failures.
authors.affiliation: Department of Urology, National Naval Medical Center, Bethesda, Maryland 20889-5000, USA.
authors.forename: P
authors.initials: P
authors.lastname: Kelty
authors.forename: H
authors.initials: H
authors.lastname: Frazier
authors.forename: K
authors.initials: K
authors.lastname: O'Connell
authors.forename: B C
authors.initials: BC
authors.lastname: Ghosh
mesh_terms: D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D005500:Follow-Up Studies; D018237:Germinoma / Q000401:mortality / Q000628:therapy*; D006801:Humans; D008197:Lymph Node Excision; D008297:Male; D009919:Orchiectomy; D011379:Prognosis; D018714:Radiotherapy, Adjuvant; D012189:Retrospective Studies; D015996:Survival Rate; D013736:Testicular Neoplasms / Q000401:mortality / Q000628:therapy*